To date, studies exploring the role of TRPCs in cancer proliferation have mainly focused on TRPC1 and TRPC6, for which spider venom peptide GsMTx4 has been reported to be an allosteric inhibitor [46,47]. This evidence concerns the gene TRPC1 and cancer.